DE60008573D1 - Oligobenzimidazolderivate und ihre verwendung als dna-transfektionsmittel - Google Patents

Oligobenzimidazolderivate und ihre verwendung als dna-transfektionsmittel

Info

Publication number
DE60008573D1
DE60008573D1 DE60008573T DE60008573T DE60008573D1 DE 60008573 D1 DE60008573 D1 DE 60008573D1 DE 60008573 T DE60008573 T DE 60008573T DE 60008573 T DE60008573 T DE 60008573T DE 60008573 D1 DE60008573 D1 DE 60008573D1
Authority
DE
Germany
Prior art keywords
nucleic acids
group
vivo
nr4r5
oligobenzimidazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60008573T
Other languages
English (en)
Other versions
DE60008573T2 (de
Inventor
Daniel Scherman
Michel Bessodes
Bruno Pitard
Javier Soto
Gerardo Byk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9913934A external-priority patent/FR2800736B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE60008573D1 publication Critical patent/DE60008573D1/de
Application granted granted Critical
Publication of DE60008573T2 publication Critical patent/DE60008573T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60008573T 1999-11-05 2000-11-06 Oligobenzimidazolderivate und ihre verwendung als dna-transfektionsmittel Expired - Fee Related DE60008573T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9913934A FR2800736B1 (fr) 1999-11-05 1999-11-05 Derives d'oligobenzimidazoles, les compositions les contenant et leurs utilisations
FR9913934 1999-11-05
US17464800P 2000-01-05 2000-01-05
US174648P 2000-01-05
PCT/FR2000/003087 WO2001032630A1 (fr) 1999-11-05 2000-11-06 Derives d'oligobenzimidazoles et leur utilisation comme agents de transfection d'adn

Publications (2)

Publication Number Publication Date
DE60008573D1 true DE60008573D1 (de) 2004-04-01
DE60008573T2 DE60008573T2 (de) 2004-12-16

Family

ID=26235148

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60008573T Expired - Fee Related DE60008573T2 (de) 1999-11-05 2000-11-06 Oligobenzimidazolderivate und ihre verwendung als dna-transfektionsmittel

Country Status (12)

Country Link
EP (1) EP1230223B1 (de)
JP (1) JP2003513078A (de)
AT (1) ATE260261T1 (de)
AU (1) AU1399801A (de)
CA (1) CA2389778A1 (de)
DE (1) DE60008573T2 (de)
DK (1) DK1230223T3 (de)
ES (1) ES2211644T3 (de)
IL (1) IL149153A0 (de)
MX (1) MXPA02004449A (de)
PT (1) PT1230223E (de)
WO (1) WO2001032630A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320627D0 (en) * 2003-09-03 2003-10-01 Imp College Innovations Ltd Methods
GB201506660D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds
GB201506658D0 (en) 2015-04-20 2015-06-03 Cellcentric Ltd Pharmaceutical compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207393A (en) * 1983-08-05 1987-03-31 Neal Lloyd First Staining dna in living cells
NZ239893A (en) * 1990-09-25 1993-11-25 Hoechst Japan A method for introducing a foreign dna into a cell

Also Published As

Publication number Publication date
DK1230223T3 (da) 2004-06-14
JP2003513078A (ja) 2003-04-08
EP1230223A1 (de) 2002-08-14
MXPA02004449A (es) 2002-09-02
WO2001032630A1 (fr) 2001-05-10
ES2211644T3 (es) 2004-07-16
PT1230223E (pt) 2004-07-30
CA2389778A1 (fr) 2001-05-10
IL149153A0 (en) 2002-11-10
AU1399801A (en) 2001-05-14
EP1230223B1 (de) 2004-02-25
DE60008573T2 (de) 2004-12-16
ATE260261T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
ATE310152T1 (de) Verdickte säure zusammensetzungen und ihre verwendungen
HUP0300850A2 (hu) Gyűrűs béta-aminosav-származékok mint mátrix metalloproteázok és a TNF-alfa inhibitorok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DK1161428T3 (da) Pyrimidinforbindelser
HUP0004529A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szulfonilezett dipeptid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk
DE50100893D1 (de) Verfahren zur Herstellung von 3,4-Alkylendioxythiophen-2,5-dicarbonsäurederivaten
DE60118776D1 (de) Polymerisierbare, flüssigkristalline dioxetane, deren herstellung und verwendung
EA199901047A1 (ru) Жидкие производные бензизохинолина
IL108259A0 (en) Piperazine derivates, their preparation and pharmaceutical compositions containing them
IL125048A0 (en) Barbituric acid derivatives processes for their production and pharmaceutical agents containing these compounds
HUP0002311A2 (hu) Ergolinszármazékok és szomatosztatin receptorként való alkalmazásuk
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
EP1342720A3 (de) Epoxysuccinamid-Derivate
EP1288275A3 (de) Electrochrome Lösung, enthaltend eine Hydrazonverbindung und mit dieser hergestellte Vorrichtung
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
DE60008573D1 (de) Oligobenzimidazolderivate und ihre verwendung als dna-transfektionsmittel
MX2009005782A (es) Derivados de pirano, procedimiento de preparacion y uso de los mismos en perfumeria y saborizantes.
HUP0301258A2 (hu) Aminoizokinolincsoportot tartalmazó trombin inhibitorok és alkalmazásuk gyógyszerkészítmények előállítására
DE60004669D1 (de) Indolocarbazolalkaloide aus einer marinen actinomycete
TR200003877T2 (tr) İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri
NZ504299A (en) 1-aza-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them
ATE205853T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
BG108423A (en) Dihydroimidazo[5,1-a]beta-carboline derivatives, method for preparing same and use thereof as medicine
ATE160571T1 (de) 5-(1-fluorovinyl)-1h-pyrimidin-2,4-dion-derivat als antineoplastische mittel
AU2002321381A1 (en) Method for preparing organic, in particular lithocholic acid, nanotubes and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee